Concert Pharmaceuticals raises $66.4M through share offering and warrant exercise

Jun. 06, 2022 4:07 PM ETConcert Pharmaceuticals, Inc. (CNCE)By: Preeti Singh, SA News Editor
  • Concert Pharmaceuticals (NASDAQ:CNCE) has raised $66.4M in gross proceeds through its previously announced underwritten public offering of 10M shares and exercise of warrants.
  • Each share was offered at $4.75.
  • Aggregate gross proceeds to Concert from this offering were $47.5M.
  • The pharma firm also received $18.9M upon the exercise of tranche 1 warrants to purchase 3,981 shares of Series X1 Preferred Stock issued to BVF Partners and RA Capital Management in Nov 2021.
  • Shares have slipped ~2% in extended trading

Recommended For You


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.